NKTR
Nektar Therapeutics · Healthcare
SVP and Chief Commercial Officer John Northcott sold $53K of Nektar Therapeutics
Sold$53,129
$10.95Price
4,852Shares
−2%Stake
What NKTR did after the filing
- The stock from Fri, Feb 18 close, $158.25
- −45.7%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Apr 4 close.
Traded Wed, Feb 16. Filed Fri, Feb 18, 1:15 PM ET, during the session. Returns use the Feb 18 close and the Apr 4 close. Not investment advice.